Stephen Hillerman

CDK4/6 and IGF1 Receptor Inhibitors Synergize to Suppress the Growth of p16INK4A-Deficient Pancreatic Cancers

Direct and Catalytic C ‐Glycosylation of Arenes: Expeditious Synthesis of the Remdesivir Nucleoside**

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis

Targeting TRK family proteins in cancer

Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer

Macrophages as regulators of tumour immunity and immunotherapy

IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination

Metastatic colonization by circulating tumour cells

Microenvironmental regulation of tumor progression and metastasis

Radiomics: the bridge between medical imaging and personalized medicine

Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma

The history and future of targeting cyclin-dependent kinases in cancer therapy

The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer

Mechanisms of Insulin Action and Insulin Resistance

Development of a Scalable Synthesis to VEGFR Inhibitor AG-28262

Insulin Receptor Isoforms in Physiology and Disease: An Updated View

Combination therapy in combating cancer

Cyanoamidine Cyclization Approach to Remdesivir’s Nucleobase

Functional Oligothiophenes: Molecular Design for Multidimensional Nanoarchitectures and Their Applications

Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals

New iminophosphorane-mediated synthesis of thieno[3′,2′:4,5]thieno[3,2-d]pyrimidin-4(3H)-ones and 5H-2,3-dithia-5,7-diaza-cyclopenta[c,d]indenes

Microwave-based synthesis of novel thienopyrimidine bioisosteres of gefitinib

Chemistry and Biology Of Multicomponent Reactions

BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR

Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model

Design and SAR of thienopyrimidine and thienopyridine inhibitors of VEGFR-2 kinase activity